Junior doctors in jobs scramble
From Mmc
Junior doctors in jobs scramble
Sarah-Kate Templeton, Health Editor
JUNIOR doctors will face even tougher competition for jobs this year with close to three applications expected for each position, National Health Service managers have warned.
NHS Employers, the agency responsible for staffing the health service, has warned that a Court of Appeal ruling means doctors trained in Britain will need to compete for posts to train as consultants alongside doctors from around the world who want to practise in the UK.
If the juniors do not obtain a training post, they will not be able to become hospital consultants or GPs.
Sian Thomas of NHS Employers said: �There are about 9,000 posts for around 23,000 estimated applicants - that�s what the Department of Health has told us.
�One could argue that the more competition you have, the better quality you will get. It is a good thing for patients that there is competition for jobs - it should mean they get the best doctors wherever they live.�
She admitted, however, that taxpayers� money would be wasted if junior doctors trained in Britain decide to take consultant posts overseas.
The British Medical Association blames the health department for continuing to recruit medics from overseas at the same time as increasing the number of medical graduates from British universities.
Meanwhile, patients are suffering from a postcode lottery of drug prescription eight years after the government set up a body to get rid of the problem, a report by a parliamentary committee will say this week.
The health select committee is expected to say that the National Institute for Health and Clinical Excellence (Nice) has failed to ensure that medicines available in one area are not denied in neighbouring districts.
An inquiry by the committee of MPs is also expected to say that the NHS, which spends about £90 billion a year, should not need to withhold life-saving medicines. It is likely to say that restrictions on drugs to treat cancer or Alzheimer�s could be avoided. The MPs are expected to recommend that Nice gets greater powers to force NHS trusts to make drugs it has approved available to all patients.
